Cas:61630-32-8 4-Androsten-4-ol-3,17-dione acetate manufacturer & supplier

We serve Chemical Name:4-Androsten-4-ol-3,17-dione acetate CAS:61630-32-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Androsten-4-ol-3,17-dione acetate

Chemical Name:4-Androsten-4-ol-3,17-dione acetate
CAS.NO:61630-32-8
Synonyms:[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate
Molecular Formula:C21H28O4
Molecular Weight:344.44500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:501.2ºC at 760 mmHg
Density:1.18g/cm3
Index of Refraction:1.548
PSA:60.44000
Exact Mass:344.19900
LogP:3.97820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like [(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate Use and application,[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate technical grade,usp/ep/jp grade.


Related News: This not only makes it easier to remove enzyme residues from the desired product, but also ensures valuable high turnover enzymes can be reused multiple times without compromising their activity. 2-Amino-5,7-diphenyl-3-phenylazopyrazolo(1,5-a)pyrimidine manufacturers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 1,7-bis-(5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-heptane suppliers Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD welcomed the announcement, saying: “I’m really pleased that Ballina will play such an important role in the production of COVID-19 vaccines, which have saved millions of lives around the world. (5S,13S)-19,21-Dimethoxy-5,13-dimethyl-3,6,9,12,15-pentaoxa-bicyclo[15.3.1]henicosa-1(20),17(21),18-triene vendor & factory The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. ,CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells.